1 Study Coverage 1.1 Anti-Infective Medications Product Introduction 1.2 Market Segments 1.3 Key Anti-Infective Medications Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Anti-Infective Medications Market Size Growth Rate by Type 1.4.2 Antivirals 1.4.3 Antibacterials 1.4.4 Antifungals 1.5 Market by Application 1.5.1 Global Anti-Infective Medications Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Online Pharmacies 1.5.4 Retail Pharmacies 1.6 Coronavirus Disease 2019 (Covid-19): Anti-Infective Medications Industry Impact 1.6.1 How the Covid-19 is Affecting the Anti-Infective Medications Industry 1.6.1.1 Anti-Infective Medications Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Anti-Infective Medications Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Anti-Infective Medications Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Anti-Infective Medications Market Size Estimates and Forecasts 2.1.1 Global Anti-Infective Medications Revenue 2015-2026 2.1.2 Global Anti-Infective Medications Sales 2015-2026 2.2 Anti-Infective Medications Market Size by Region: 2020 Versus 2026 2.2.1 Global Anti-Infective Medications Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Anti-Infective Medications Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Anti-Infective Medications Competitor Landscape by Players 3.1 Anti-Infective Medications Sales by Manufacturers 3.1.1 Anti-Infective Medications Sales by Manufacturers (2015-2020) 3.1.2 Anti-Infective Medications Sales Market Share by Manufacturers (2015-2020) 3.2 Anti-Infective Medications Revenue by Manufacturers 3.2.1 Anti-Infective Medications Revenue by Manufacturers (2015-2020) 3.2.2 Anti-Infective Medications Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Anti-Infective Medications Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Anti-Infective Medications Revenue in 2019 3.2.5 Global Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Anti-Infective Medications Price by Manufacturers 3.4 Anti-Infective Medications Manufacturing Base Distribution, Product Types 3.4.1 Anti-Infective Medications Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Anti-Infective Medications Product Type 3.4.3 Date of International Manufacturers Enter into Anti-Infective Medications Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Anti-Infective Medications Market Size by Type (2015-2020) 4.1.1 Global Anti-Infective Medications Sales by Type (2015-2020) 4.1.2 Global Anti-Infective Medications Revenue by Type (2015-2020) 4.1.3 Anti-Infective Medications Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Anti-Infective Medications Market Size Forecast by Type (2021-2026) 4.2.1 Global Anti-Infective Medications Sales Forecast by Type (2021-2026) 4.2.2 Global Anti-Infective Medications Revenue Forecast by Type (2021-2026) 4.2.3 Anti-Infective Medications Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Anti-Infective Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Anti-Infective Medications Market Size by Application (2015-2020) 5.1.1 Global Anti-Infective Medications Sales by Application (2015-2020) 5.1.2 Global Anti-Infective Medications Revenue by Application (2015-2020) 5.1.3 Anti-Infective Medications Price by Application (2015-2020) 5.2 Anti-Infective Medications Market Size Forecast by Application (2021-2026) 5.2.1 Global Anti-Infective Medications Sales Forecast by Application (2021-2026) 5.2.2 Global Anti-Infective Medications Revenue Forecast by Application (2021-2026) 5.2.3 Global Anti-Infective Medications Price Forecast by Application (2021-2026) 6 North America 6.1 North America Anti-Infective Medications by Country 6.1.1 North America Anti-Infective Medications Sales by Country 6.1.2 North America Anti-Infective Medications Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Anti-Infective Medications Market Facts & Figures by Type 6.3 North America Anti-Infective Medications Market Facts & Figures by Application 7 Europe 7.1 Europe Anti-Infective Medications by Country 7.1.1 Europe Anti-Infective Medications Sales by Country 7.1.2 Europe Anti-Infective Medications Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Anti-Infective Medications Market Facts & Figures by Type 7.3 Europe Anti-Infective Medications Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Anti-Infective Medications by Region 8.1.1 Asia Pacific Anti-Infective Medications Sales by Region 8.1.2 Asia Pacific Anti-Infective Medications Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Anti-Infective Medications Market Facts & Figures by Type 8.3 Asia Pacific Anti-Infective Medications Market Facts & Figures by Application 9 Latin America 9.1 Latin America Anti-Infective Medications by Country 9.1.1 Latin America Anti-Infective Medications Sales by Country 9.1.2 Latin America Anti-Infective Medications Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Anti-Infective Medications Market Facts & Figures by Type 9.3 Central & South America Anti-Infective Medications Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Anti-Infective Medications by Country 10.1.1 Middle East and Africa Anti-Infective Medications Sales by Country 10.1.2 Middle East and Africa Anti-Infective Medications Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Anti-Infective Medications Market Facts & Figures by Type 10.3 Middle East and Africa Anti-Infective Medications Market Facts & Figures by Application 11 Company Profiles 11.1 Abbott 11.1.1 Abbott Corporation Information 11.1.2 Abbott Description, Business Overview and Total Revenue 11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Abbott Anti-Infective Medications Products Offered 11.1.5 Abbott Recent Development 11.2 Astellas Pharma 11.2.1 Astellas Pharma Corporation Information 11.2.2 Astellas Pharma Description, Business Overview and Total Revenue 11.2.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Astellas Pharma Anti-Infective Medications Products Offered 11.2.5 Astellas Pharma Recent Development 11.3 Bayer 11.3.1 Bayer Corporation Information 11.3.2 Bayer Description, Business Overview and Total Revenue 11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Bayer Anti-Infective Medications Products Offered 11.3.5 Bayer Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Corporation Information 11.4.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue 11.4.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Bristol-Myers Squibb Anti-Infective Medications Products Offered 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Daiichi Sankyo 11.5.1 Daiichi Sankyo Corporation Information 11.5.2 Daiichi Sankyo Description, Business Overview and Total Revenue 11.5.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Daiichi Sankyo Anti-Infective Medications Products Offered 11.5.5 Daiichi Sankyo Recent Development 11.6 GlaxoSmithKline 11.6.1 GlaxoSmithKline Corporation Information 11.6.2 GlaxoSmithKline Description, Business Overview and Total Revenue 11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 11.6.4 GlaxoSmithKline Anti-Infective Medications Products Offered 11.6.5 GlaxoSmithKline Recent Development 11.7 Merck 11.7.1 Merck Corporation Information 11.7.2 Merck Description, Business Overview and Total Revenue 11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Merck Anti-Infective Medications Products Offered 11.7.5 Merck Recent Development 11.8 Novartis 11.8.1 Novartis Corporation Information 11.8.2 Novartis Description, Business Overview and Total Revenue 11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Novartis Anti-Infective Medications Products Offered 11.8.5 Novartis Recent Development 11.9 Pfizer 11.9.1 Pfizer Corporation Information 11.9.2 Pfizer Description, Business Overview and Total Revenue 11.9.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Pfizer Anti-Infective Medications Products Offered 11.9.5 Pfizer Recent Development 11.10 Roche 11.10.1 Roche Corporation Information 11.10.2 Roche Description, Business Overview and Total Revenue 11.10.3 Roche Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Roche Anti-Infective Medications Products Offered 11.10.5 Roche Recent Development 11.1 Abbott 11.1.1 Abbott Corporation Information 11.1.2 Abbott Description, Business Overview and Total Revenue 11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Abbott Anti-Infective Medications Products Offered 11.1.5 Abbott Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Anti-Infective Medications Market Estimates and Projections by Region 12.1.1 Global Anti-Infective Medications Sales Forecast by Regions 2021-2026 12.1.2 Global Anti-Infective Medications Revenue Forecast by Regions 2021-2026 12.2 North America Anti-Infective Medications Market Size Forecast (2021-2026) 12.2.1 North America: Anti-Infective Medications Sales Forecast (2021-2026) 12.2.2 North America: Anti-Infective Medications Revenue Forecast (2021-2026) 12.2.3 North America: Anti-Infective Medications Market Size Forecast by Country (2021-2026) 12.3 Europe Anti-Infective Medications Market Size Forecast (2021-2026) 12.3.1 Europe: Anti-Infective Medications Sales Forecast (2021-2026) 12.3.2 Europe: Anti-Infective Medications Revenue Forecast (2021-2026) 12.3.3 Europe: Anti-Infective Medications Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Anti-Infective Medications Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Anti-Infective Medications Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Anti-Infective Medications Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Anti-Infective Medications Market Size Forecast by Region (2021-2026) 12.5 Latin America Anti-Infective Medications Market Size Forecast (2021-2026) 12.5.1 Latin America: Anti-Infective Medications Sales Forecast (2021-2026) 12.5.2 Latin America: Anti-Infective Medications Revenue Forecast (2021-2026) 12.5.3 Latin America: Anti-Infective Medications Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Anti-Infective Medications Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Anti-Infective Medications Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Anti-Infective Medications Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Anti-Infective Medications Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Anti-Infective Medications Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Anti-Infective Medications Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details

List of Tables Table 1. Anti-Infective Medications Market Segments Table 2. Ranking of Global Top Anti-Infective Medications Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Anti-Infective Medications Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Antivirals Table 5. Major Manufacturers of Antibacterials Table 6. Major Manufacturers of Antifungals Table 7. COVID-19 Impact Global Market: (Four Anti-Infective Medications Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Anti-Infective Medications Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Anti-Infective Medications Players to Combat Covid-19 Impact Table 12. Global Anti-Infective Medications Market Size Growth Rate by Application 2020-2026 (K Units) Table 13. Global Anti-Infective Medications Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 14. Global Anti-Infective Medications Sales by Regions 2015-2020 (K Units) Table 15. Global Anti-Infective Medications Sales Market Share by Regions (2015-2020) Table 16. Global Anti-Infective Medications Revenue by Regions 2015-2020 (US$ Million) Table 17. Global Anti-Infective Medications Sales by Manufacturers (2015-2020) (K Units) Table 18. Global Anti-Infective Medications Sales Share by Manufacturers (2015-2020) Table 19. Global Anti-Infective Medications Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 20. Global Anti-Infective Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Medications as of 2019) Table 21. Anti-Infective Medications Revenue by Manufacturers (2015-2020) (US$ Million) Table 22. Anti-Infective Medications Revenue Share by Manufacturers (2015-2020) Table 23. Key Manufacturers Anti-Infective Medications Price (2015-2020) (USD/Unit) Table 24. Anti-Infective Medications Manufacturers Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Anti-Infective Medications Product Type Table 26. Date of International Manufacturers Enter into Anti-Infective Medications Market Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans Table 28. Global Anti-Infective Medications Sales by Type (2015-2020) (K Units) Table 29. Global Anti-Infective Medications Sales Share by Type (2015-2020) Table 30. Global Anti-Infective Medications Revenue by Type (2015-2020) (US$ Million) Table 31. Global Anti-Infective Medications Revenue Share by Type (2015-2020) Table 32. Anti-Infective Medications Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 33. Global Anti-Infective Medications Sales by Application (2015-2020) (K Units) Table 34. Global Anti-Infective Medications Sales Share by Application (2015-2020) Table 35. North America Anti-Infective Medications Sales by Country (2015-2020) (K Units) Table 36. North America Anti-Infective Medications Sales Market Share by Country (2015-2020) Table 37. North America Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million) Table 38. North America Anti-Infective Medications Revenue Market Share by Country (2015-2020) Table 39. North America Anti-Infective Medications Sales by Type (2015-2020) (K Units) Table 40. North America Anti-Infective Medications Sales Market Share by Type (2015-2020) Table 41. North America Anti-Infective Medications Sales by Application (2015-2020) (K Units) Table 42. North America Anti-Infective Medications Sales Market Share by Application (2015-2020) Table 43. Europe Anti-Infective Medications Sales by Country (2015-2020) (K Units) Table 44. Europe Anti-Infective Medications Sales Market Share by Country (2015-2020) Table 45. Europe Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million) Table 46. Europe Anti-Infective Medications Revenue Market Share by Country (2015-2020) Table 47. Europe Anti-Infective Medications Sales by Type (2015-2020) (K Units) Table 48. Europe Anti-Infective Medications Sales Market Share by Type (2015-2020) Table 49. Europe Anti-Infective Medications Sales by Application (2015-2020) (K Units) Table 50. Europe Anti-Infective Medications Sales Market Share by Application (2015-2020) Table 51. Asia Pacific Anti-Infective Medications Sales by Region (2015-2020) (K Units) Table 52. Asia Pacific Anti-Infective Medications Sales Market Share by Region (2015-2020) Table 53. Asia Pacific Anti-Infective Medications Revenue by Region (2015-2020) (US$ Million) Table 54. Asia Pacific Anti-Infective Medications Revenue Market Share by Region (2015-2020) Table 55. Asia Pacific Anti-Infective Medications Sales by Type (2015-2020) (K Units) Table 56. Asia Pacific Anti-Infective Medications Sales Market Share by Type (2015-2020) Table 57. Asia Pacific Anti-Infective Medications Sales by Application (2015-2020) (K Units) Table 58. Asia Pacific Anti-Infective Medications Sales Market Share by Application (2015-2020) Table 59. Latin America Anti-Infective Medications Sales by Country (2015-2020) (K Units) Table 60. Latin America Anti-Infective Medications Sales Market Share by Country (2015-2020) Table 61. Latin Americaa Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million) Table 62. Latin America Anti-Infective Medications Revenue Market Share by Country (2015-2020) Table 63. Latin America Anti-Infective Medications Sales by Type (2015-2020) (K Units) Table 64. Latin America Anti-Infective Medications Sales Market Share by Type (2015-2020) Table 65. Latin America Anti-Infective Medications Sales by Application (2015-2020) (K Units) Table 66. Latin America Anti-Infective Medications Sales Market Share by Application (2015-2020) Table 67. Middle East and Africa Anti-Infective Medications Sales by Country (2015-2020) (K Units) Table 68. Middle East and Africa Anti-Infective Medications Sales Market Share by Country (2015-2020) Table 69. Middle East and Africa Anti-Infective Medications Revenue by Country (2015-2020) (US$ Million) Table 70. Middle East and Africa Anti-Infective Medications Revenue Market Share by Country (2015-2020) Table 71. Middle East and Africa Anti-Infective Medications Sales by Type (2015-2020) (K Units) Table 72. Middle East and Africa Anti-Infective Medications Sales Market Share by Type (2015-2020) Table 73. Middle East and Africa Anti-Infective Medications Sales by Application (2015-2020) (K Units) Table 74. Middle East and Africa Anti-Infective Medications Sales Market Share by Application (2015-2020) Table 75. Abbott Corporation Information Table 76. Abbott Description and Major Businesses Table 77. Abbott Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. Abbott Product Table 79. Abbott Recent Development Table 80. Astellas Pharma Corporation Information Table 81. Astellas Pharma Description and Major Businesses Table 82. Astellas Pharma Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Astellas Pharma Product Table 84. Astellas Pharma Recent Development Table 85. Bayer Corporation Information Table 86. Bayer Description and Major Businesses Table 87. Bayer Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. Bayer Product Table 89. Bayer Recent Development Table 90. Bristol-Myers Squibb Corporation Information Table 91. Bristol-Myers Squibb Description and Major Businesses Table 92. Bristol-Myers Squibb Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Bristol-Myers Squibb Product Table 94. Bristol-Myers Squibb Recent Development Table 95. Daiichi Sankyo Corporation Information Table 96. Daiichi Sankyo Description and Major Businesses Table 97. Daiichi Sankyo Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Daiichi Sankyo Product Table 99. Daiichi Sankyo Recent Development Table 100. GlaxoSmithKline Corporation Information Table 101. GlaxoSmithKline Description and Major Businesses Table 102. GlaxoSmithKline Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. GlaxoSmithKline Product Table 104. GlaxoSmithKline Recent Development Table 105. Merck Corporation Information Table 106. Merck Description and Major Businesses Table 107. Merck Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Merck Product Table 109. Merck Recent Development Table 110. Novartis Corporation Information Table 111. Novartis Description and Major Businesses Table 112. Novartis Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 113. Novartis Product Table 114. Novartis Recent Development Table 115. Pfizer Corporation Information Table 116. Pfizer Description and Major Businesses Table 117. Pfizer Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 118. Pfizer Product Table 119. Pfizer Recent Development Table 120. Roche Corporation Information Table 121. Roche Description and Major Businesses Table 122. Roche Anti-Infective Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. Roche Product Table 124. Roche Recent Development Table 125. Global Anti-Infective Medications Sales Forecast by Regions (2021-2026) (K Units) Table 126. Global Anti-Infective Medications Sales Market Share Forecast by Regions (2021-2026) Table 127. Global Anti-Infective Medications Revenue Forecast by Regions (2021-2026) (US$ Million) Table 128. Global Anti-Infective Medications Revenue Market Share Forecast by Regions (2021-2026) Table 129. North America: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units) Table 130. North America: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million) Table 131. Europe: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units) Table 132. Europe: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million) Table 133. Asia Pacific: Anti-Infective Medications Sales Forecast by Region (2021-2026) (K Units) Table 134. Asia Pacific: Anti-Infective Medications Revenue Forecast by Region (2021-2026) (US$ Million) Table 135. Latin America: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units) Table 136. Latin America: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million) Table 137. Middle East and Africa: Anti-Infective Medications Sales Forecast by Country (2021-2026) (K Units) Table 138. Middle East and Africa: Anti-Infective Medications Revenue Forecast by Country (2021-2026) (US$ Million) Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 140. Key Challenges Table 141. Market Risks Table 142. Main Points Interviewed from Key Anti-Infective Medications Players Table 143. Anti-Infective Medications Customers List Table 144. Anti-Infective Medications Distributors List Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Anti-Infective Medications Product Picture Figure 2. Global Anti-Infective Medications Sales Market Share by Type in 2020 & 2026 Figure 3. Antivirals Product Picture Figure 4. Antibacterials Product Picture Figure 5. Antifungals Product Picture Figure 6. Global Anti-Infective Medications Sales Market Share by Application in 2020 & 2026 Figure 7. Hospital Pharmacies Figure 8. Online Pharmacies Figure 9. Retail Pharmacies Figure 10. Anti-Infective Medications Report Years Considered Figure 11. Global Anti-Infective Medications Market Size 2015-2026 (US$ Million) Figure 12. Global Anti-Infective Medications Sales 2015-2026 (K Units) Figure 13. Global Anti-Infective Medications Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Global Anti-Infective Medications Sales Market Share by Region (2015-2020) Figure 15. Global Anti-Infective Medications Sales Market Share by Region in 2019 Figure 16. Global Anti-Infective Medications Revenue Market Share by Region (2015-2020) Figure 17. Global Anti-Infective Medications Revenue Market Share by Region in 2019 Figure 18. Global Anti-Infective Medications Sales Share by Manufacturer in 2019 Figure 19. The Top 10 and 5 Players Market Share by Anti-Infective Medications Revenue in 2019 Figure 20. Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 21. Global Anti-Infective Medications Sales Market Share by Type (2015-2020) Figure 22. Global Anti-Infective Medications Sales Market Share by Type in 2019 Figure 23. Global Anti-Infective Medications Revenue Market Share by Type (2015-2020) Figure 24. Global Anti-Infective Medications Revenue Market Share by Type in 2019 Figure 25. Global Anti-Infective Medications Market Share by Price Range (2015-2020) Figure 26. Global Anti-Infective Medications Sales Market Share by Application (2015-2020) Figure 27. Global Anti-Infective Medications Sales Market Share by Application in 2019 Figure 28. Global Anti-Infective Medications Revenue Market Share by Application (2015-2020) Figure 29. Global Anti-Infective Medications Revenue Market Share by Application in 2019 Figure 30. North America Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units) Figure 31. North America Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million) Figure 32. North America Anti-Infective Medications Sales Market Share by Country in 2019 Figure 33. North America Anti-Infective Medications Revenue Market Share by Country in 2019 Figure 34. U.S. Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 35. U.S. Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Canada Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 37. Canada Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. North America Anti-Infective Medications Market Share by Type in 2019 Figure 39. North America Anti-Infective Medications Market Share by Application in 2019 Figure 40. Europe Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units) Figure 41. Europe Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million) Figure 42. Europe Anti-Infective Medications Sales Market Share by Country in 2019 Figure 43. Europe Anti-Infective Medications Revenue Market Share by Country in 2019 Figure 44. Germany Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 45. Germany Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. France Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 47. France Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. U.K. Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 49. U.K. Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Italy Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 51. Italy Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Russia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 53. Russia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Europe Anti-Infective Medications Market Share by Type in 2019 Figure 55. Europe Anti-Infective Medications Market Share by Application in 2019 Figure 56. Asia Pacific Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units) Figure 57. Asia Pacific Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million) Figure 58. Asia Pacific Anti-Infective Medications Sales Market Share by Region in 2019 Figure 59. Asia Pacific Anti-Infective Medications Revenue Market Share by Region in 2019 Figure 60. China Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 61. China Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Japan Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 63. Japan Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. South Korea Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 65. South Korea Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. India Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 67. India Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Australia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 69. Australia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Taiwan Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 71. Taiwan Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Indonesia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 73. Indonesia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Thailand Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 75. Thailand Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Malaysia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 77. Malaysia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Philippines Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 79. Philippines Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Vietnam Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 81. Vietnam Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Asia Pacific Anti-Infective Medications Market Share by Type in 2019 Figure 83. Asia Pacific Anti-Infective Medications Market Share by Application in 2019 Figure 84. Latin America Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units) Figure 85. Latin America Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million) Figure 86. Latin America Anti-Infective Medications Sales Market Share by Country in 2019 Figure 87. Latin America Anti-Infective Medications Revenue Market Share by Country in 2019 Figure 88. Mexico Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 89. Mexico Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Brazil Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 91. Brazil Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Argentina Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 93. Argentina Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Latin America Anti-Infective Medications Market Share by Type in 2019 Figure 95. Latin America Anti-Infective Medications Market Share by Application in 2019 Figure 96. Middle East and Africa Anti-Infective Medications Sales Growth Rate 2015-2020 (K Units) Figure 97. Middle East and Africa Anti-Infective Medications Revenue Growth Rate 2015-2020 (US$ Million) Figure 98. Middle East and Africa Anti-Infective Medications Sales Market Share by Country in 2019 Figure 99. Middle East and Africa Anti-Infective Medications Revenue Market Share by Country in 2019 Figure 100. Turkey Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 101. Turkey Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 102. Saudi Arabia Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 103. Saudi Arabia Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. U.A.E Anti-Infective Medications Sales Growth Rate (2015-2020) (K Units) Figure 105. U.A.E Anti-Infective Medications Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. Middle East and Africa Anti-Infective Medications Market Share by Type in 2019 Figure 107. Middle East and Africa Anti-Infective Medications Market Share by Application in 2019 Figure 108. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 110. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 111. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 112. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 113. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 114. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 115. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 116. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 117. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 118. North America Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units) Figure 119. North America Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 120. Europe Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units) Figure 121. Europe Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 122. Asia Pacific Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units) Figure 123. Asia Pacific Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 124. Latin America Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units) Figure 125. Latin America Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 126. Middle East and Africa Anti-Infective Medications Sales Growth Rate Forecast (2021-2026) (K Units) Figure 127. Middle East and Africa Anti-Infective Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 128. Porter's Five Forces Analysis Figure 129. Channels of Distribution Figure 130. Distributors Profiles Figure 131. Bottom-up and Top-down Approaches for This Report Figure 132. Data Triangulation Figure 133. Key Executives Interviewed

Abbott Astellas Pharma Bayer Bristol-Myers Squibb Daiichi Sankyo GlaxoSmithKline Merck Novartis Pfizer Roche